Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study aimed to evaluate the efficacy and safety of escitalopram in the treatment of
depressive patients with acute coronary artery syndrome (CAS).